Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tricyclic compounds as MRP1-inhibitors

Tricyclic compounds as MRP1-inhibitors

US Patent 6673809 · Granted Jan 6, 2004

Estimated economic value: $415,321,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multi-metal material build device using laser 3D printing, and working method th2025
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2025
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediate2024
Pharmaceutical compounds for treatment of medical disorders2024
Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflamm2024
Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of med2023
Amino compounds for treatment of immune and inflammatory disorders2023
Amide compounds for treatment of immune and inflammatory disorders2023
Targeted drug rescue with novel compositions, combinations, and methods thereof2022
Pharmaceutical compounds for treatment of medical disorders2022